eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > External Ear Diseases
Malignant Tumors of the Temporal Bone: Treatment
Updated: Mar 19, 2009
Treatment
Medical Therapy
Primary radiation is ineffective for curative treatment. In the most extreme cases in which contraindications to surgery are serious deterrents to surgery, palliative radiation and chemotherapy may be offered. The literature supports a beneficial effect of adjunctive radiation on survival, but no well-controlled studies have been performed. Postoperative radiation treatment may be indicated in advanced disease. Most authors advocate full course postoperative radiation to stage T3 or T4 tumors as defined by the University of Pittsburgh staging system. Some authors also recommend radiation for T2 disease.12
The literature supports a beneficial effect of postoperative radiation on survival.1,5 The temporal bone and neck should be treated with 50-60 Gy for tumors staged T3 and T4. Radiation may also be indicated for smaller lesions.
Preoperative chemotherapy was reviewed by Nakagawa et al in a retrospective series of patients treated with preoperative chemoradiation or with chemoradiation alone).13 Four of 8 patients treated with Chemoradiation (5-Flourouracil or a fluoropyrimidine complex during external beam radiation with a dose of 40Gy) followed by chemotherapy in one case, were free of disease at 24-47 months. Pemberton et al reported 53% cancer-specific survival of 123 patients treated with radiotherapy alone (55 Gy).14
Surgical Therapy
In general, all patients who are medically able should undergo surgical treatment. The optimal surgery removes all of the cancer en bloc because positive margins are associated with poor survival rates. The resection procedures that can be performed for the temporal bone include a modified lateral temporal bone resection, lateral temporal bone resection, subtotal temporal bone resection, and total temporal bone resection. The specific procedures and nomenclature vary among surgeons. Adjunctive surgical procedures, including neck dissection, parotidectomy, and craniotomy, should be performed when indicated. Advanced tumors with intracranial invasion have a grave prognosis, and treatment should probably be limited to palliation with less extensive (and less morbid) surgical procedures.
Preoperative Details
Determination of tumor stage and medical status assists the surgeon in surgical planning. The goal should be complete tumor removal with preservation of CNs and other vital structures whenever possible. Preoperative planning includes mapping of disease extent by both clinical and radiographic evaluation. Tumor encroachment to the region of the internal carotid artery, sigmoid sinus, or jugular vein requires further investigation such as balloon test occlusion with xenon/CT scan (demonstrating the integrity of the contralateral cerebral artery) or angiography with venous phase (to determine dominance of the cerebral outflow). Consultation with a neurosurgeon may be necessary if involvement of the dura is suspected. The patient's medical status plays a major role in his or her tolerance of a long surgical procedure, postoperative recovery, healing, and postoperative rehabilitation.
Intraoperative Details
Management of the primary site
Hirsch and Chang have described the operative procedures in detail and the indications based on the location and stage of the tumor.15 Medina (1990) described several modifications of the lateral temporal bone dissection (LTBR) based on the location of disease.16
A modified LTBR removes the EAC and leaves the uninvolved tympanic membrane intact. This type of resection is appropriate for tumors originating in the concha without involvement of the EAC.
The LTBR includes resection of the EAC, tympanic membrane, malleus, and incus. The boundaries are the middle ear cavity and stapes medially, the mastoid cavity posteriorly, the epitympanum and zygomatic root superiorly, the temporomandibular joint (TMJ) capsule anteriorly, and the medial tympanic ring or infratemporal fossa (ITF) inferiorly. The lateral margin depends on the extent of spread. The otic capsule and facial nerve are preserved. The LTBR is appropriate for T1 and T2 tumors.
The LTBR begins with a long, postauricular incision extending from the temporal fossa into the neck. If the pinna is to be preserved, a second incision is made within the concha lateral to the lesion. If the pinna is to be resected, a preauricular incision is incorporated to the postauricular incision allowing the pinna and surrounding skin to be included in the specimen. A cortical mastoidectomy is performed and the facial nerve identified. Bone removal is extended into the zygomatic root and to the digastric ridge. An extended facial recess is made, and the incudostapedial joint is separated. The facial recess is continued inferiorly and anteriorly lateral to the facial nerve, but medial to the annulus, until the specimen is attached only at the anterior canal bony wall at the level of the temporomandibular capsule. An osteotome is used to separate the bony specimen. The parotidectomy is performed en bloc.
A subtotal temporal bone resection (STBR) is performed when invasion medial to the tympanic membrane or into the mastoid (T3 disease) is evident. In this case, the medial margin may be obtained in a piecemeal fashion, usually with a drill. The specimen includes the LTBR with additional dissection of the otic capsule and the medial bony wall of the middle ear and mastoid. The margins of resection are the sigmoid sinus and posterior fossa dura posteriorly, middle fossa dura superiorly, internal carotid artery anteriorly, jugular bulb inferiorly, and petrous apex medially. Based on the extent of tumor spread, dissection may include the condyle of the mandible, the facial nerve, dura, sigmoid sinus, and contents of the infratemporal fossa. The carotid artery is skeletonized and becomes the medial margin.
Tumor involvement of the jugular bulb requires ligation of the inferior jugular vein and proximal control of the sigmoid sinus. The facial nerve is traditionally sacrificed, with the proximal margin taken in the labyrinthine or internal auditory canal segment. However, the surgeon may elect to preserve the nerve if no indication of nerve involvement exists. The medial extent of dissection at the level of the otic capsule depends on the depth of involvement and is done piecemeal. Tumor extension into the protympanum, eustachian tube, or carotid artery is addressed with an infratemporal fossa dissection. The temporalis muscle is reflected and the zygomatic arch removed. The mandibular condyle is resected. The dissection proceeds based on the extent of disease but may include identification of the pterygoid plate, the mandibular nerve (V3), and the horizontal carotid artery and may include a temporal craniotomy.
A total TBR can be used to address T4 disease. However, this procedure is associated with significant morbidity and may not significantly improve survival in these cases of advanced disease. The total TBR includes the STBR with the additional resection of the petrous apex. The internal carotid artery may be isolated, mobilized, and preserved or resected. The sigmoid sinus, jugular vein, carotid artery, dura and CNs are removed as indicated by the extent of the tumor.
Management of the parotid and temporomandibular joint
The intraparotid lymph nodes are a first echelon drainage site for cancers of the EAC and middle ear. An adequate anterior margin for the temporal bone resection routinely involves resection of the parotid gland, temporomandibular joint, and condyle. Resection of these soft tissues will also address minimal soft tissue extension beyond the temporal bone. Ideally, this is performed en bloc with the temporal bone. A superficial parotidectomy is performed with preservation of the facial nerve for T1 and T2 tumors. When the facial nerve is resected for more advanced lesions, a total parotidectomy may be performed.
Management of the neck
Although metastasis to the neck is uncommon in limited cancers of the temporal bone, neck dissections are routinely performed. With more extensive cancers, dissection of the neck offers staging and provides control of the great vessels and exposure to the skull base. However, the presence of metastasis is associated with a poor prognosis, and neck dissection does not improve survival.5,1
Management of the dura and brain
Although involvement of the dura and brain portend for a poor prognosis, an aggressive approach includes resection of the dura and a small volume of the temporal lobe with a healthy margin.
Reconstruction
Facial nerve grafting is usually not performed in the presence of a malignant lesion. Management of facial nerve paralysis may include CN XII to VII grafting, cross facial grafting, and static procedures. Extensive resections may result in large soft tissue defects. A temporalis muscle flap can be used to fill small to medium defects. The pedicled myocutaneous trapezius flap is an excellent option for reconstruction of the soft tissue and skin defect. The pectoralis flap has limited distant reach to the resected margin. The rectus abdominus free flap and radial forearm flap are particularly suited for the area. Dural defects should be repaired primarily or with graft reconstruction.
Postoperative Details
Postoperative care consists of monitoring wound complications, flap viability, intracranial complications, and complications of CN deficits. If the dura was resected and repaired, the wound should be observed for a cerebrospinal fluid leak. Supportive care for dizziness, nausea, and vertigo is needed when the otic capsule is entered during the resection. Eye care should be instituted if postoperative facial paralysis develops or if the facial nerve is resected. Resection of CN X requires swallowing and vocal fold rehabilitation and observation for aspiration or airway complications. If the temporomandibular joint was removed, the mandible should be mobilized early to prevent contralateral dysfunction.
Complications
Complications of treatment depend on the extent of resection and the use of adjunctive radiation. Postoperative hearing loss, facial nerve paralysis, vertigo, and other CN deficits (eg, CN V, VII, VIII, IX, X, XI) may occur. Dural resection may predispose to cerebral spinal fluid leaks, meningitis, or intracranial complications. Significant complications can result from trauma to or resection of the carotid artery. Radiation has known complications of fibrosis of soft tissues, destruction of salivary gland tissue, osteoradionecrosis of the temporal bone, and possibly central nervous system effects if the field of radiation extends to intracranial tissues.
More on Malignant Tumors of the Temporal Bone |
| Overview: Malignant Tumors of the Temporal Bone |
| Workup: Malignant Tumors of the Temporal Bone |
Treatment: Malignant Tumors of the Temporal Bone |
| Follow-up: Malignant Tumors of the Temporal Bone |
| Multimedia: Malignant Tumors of the Temporal Bone |
| References |
| « Previous Page | Next Page » |
References
Moffat DA, Wagstaff SA, Hardy DG. The outcome of radical surgery and postoperative radiotherapy for squamous carcinoma of the temporal bone. Laryngoscope. Feb 2005;115(2):341-7. [Medline].
Jin YT, Tsai ST, Li C, Chang KC, Yan JJ, Chao WY, et al. Prevalence of human papillomavirus in middle ear carcinoma associated with chronic otitis media. Am J Pathol. Apr 1997;150(4):1327-33. [Medline].
Lim LH, Goh YH, Chan YM, Chong VF, Low WK. Malignancy of the temporal bone and external auditory canal. Otolaryngol Head Neck Surg. Jun 2000;122(6):882-6. [Medline].
Leonetti JP, Smith PG, Kletzker GR, Izquierdo R. Invasion patterns of advanced temporal bone malignancies. Am J Otol. May 1996;17(3):438-42. [Medline].
Moody SA, Hirsch BE, Myers EN. Squamous cell carcinoma of the external auditory canal: an evaluation of a staging system. Am J Otol. Jul 2000;21(4):582-8. [Medline].
Choi JY, Choi EC, Lee HK, Yoo JB, Kim SG, Lee WS. Mode of parotid involvement in external auditory canal carcinoma. J Laryngol Otol. Dec 2003;117(12):951-4. [Medline].
Arriaga M, Curtin H, Takahashi H, Hirsch BE, Kamerer DB. Staging proposal for external auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings. Ann Otol Rhinol Laryngol. Sep 1990;99(9 Pt 1):714-21. [Medline].
Austin JR, Stewart KL, Fawzi N. Squamous cell carcinoma of the external auditory canal. Therapeutic prognosis based on a proposed staging system. Arch Otolaryngol Head Neck Surg. Nov 1994;120(11):1228-32. [Medline].
Zhang B, Tu G, Xu G, Tang P, Hu Y. Squamous cell carcinoma of temporal bone: reported on 33 patients. Head Neck. Aug 1999;21(5):461-6. [Medline].
Gillespie MB, Francis HW, Chee N, Eisele DW. Squamous cell carcinoma of the temporal bone: a radiographic-pathologic correlation. Arch Otolaryngol Head Neck Surg. Jul 2001;127(7):803-7. [Medline].
Nyrop M, Grontved A. Cancer of the external auditory canal. Arch Otolaryngol Head Neck Surg. Jul 2002;128(7):834-7. [Medline].
Kunst H, Lavieille JP, Marres H. Squamous cell carcinoma of the temporal bone: results and management. Otol Neurotol. Jun 2008;29(4):549-52. [Medline].
Nakagawa T, Kumamoto Y, Natori Y, et al. Squamous cell carcinoma of the external auditory canal and middle ear: an operation combined with preoperative chemoradiotherapy and a free surgical margin. Otol Neurotol. Feb 2006;27(2):242-8; discussion 249. [Medline].
Pemberton LS, Swindell R, Sykes AJ. Primary radical radiotherapy for squamous cell carcinoma of the middle ear and external auditory cana--an historical series. Clin Oncol (R Coll Radiol). Jun 2006;18(5):390-4. [Medline].
Hirsch BE, Chang CYJ. Carcinoma of the temporal bone. In: Myers EN, ed. Operative Otolaryngology Head and Neck Surgery. Philadelphia, Pa: WB Saunders; 1997:1434-1458.
Medina JE, Park AO, Neely JG, Britton BH. Lateral temporal bone resections. Am J Surg. Oct 1990;160(4):427-33. [Medline].
Arriaga M, Curtin HD, Takahashi H, Kamerer DB. The role of preoperative CT scans in staging external auditory meatus carcinoma: radiologic-pathologic correlation study. Otolaryngol Head Neck Surg. Jul 1991;105(1):6-11. [Medline].
Arriaga M, Hirsch BE, Kamerer DB, Myers EN. Squamous cell carcinoma of the external auditory meatus (canal). Otolaryngol Head Neck Surg. Sep 1989;101(3):330-7. [Medline].
Conley JJ, Novack AJ. The surgical treatment of malignant tumors of the ear and temporal bone. Part I. AMA Arch Otolaryngol. Apr 1960;71:635-52. [Medline].
Crabtree JA, Britton BH, Pierce MK. Carcinoma of the external auditory canal. Laryngoscope. Mar 1976;86(3):405-15. [Medline].
Hirsch BE, Myers EN, Moody SA. Malignant tumors of the temporal bone. In: Laercio O, Selaimen S, eds. Otologia Clinia e Cirurgica. Revinter, Tijuca: 2000:319-329.
Kinney SE, Wood BG. Malignancies of the external ear canal and temporal bone: surgical techniques and results. Laryngoscope. Feb 1987;97(2):158-64. [Medline].
Manolidis S, Pappas D Jr, Von Doersten P, Jackson CG, Glasscock ME 3rd. Temporal bone and lateral skull base malignancy: experience and results with 81 patients. Am J Otol. Nov 1998;19(6 Suppl):S1-15. [Medline].
Parsons H, Lewis JS. Subtotal resection of the temporal bone for cancer of the ear. Cancer. Sep 1954;7(5):995-1001. [Medline].
Pensak ML, Gleich LL, Gluckman JL, Shumrick KA. Temporal bone carcinoma: contemporary perspectives in the skull base surgical era. Laryngoscope. Oct 1996;106(10):1234-7. [Medline].
Prasad S, Janecka IP. Efficacy of surgical treatments for squamous cell carcinoma of the temporal bone: a literature review. Otolaryngol Head Neck Surg. Mar 1994;110(3):270-80. [Medline].
Spector JG. Management of temporal bone carcinomas: a therapeutic analysis of two groups of patients and long-term followup. Otolaryngol Head Neck Surg. Jan 1991;104(1):58-66. [Medline].
Stell PM, McCormick MS. Carcinoma of the external auditory meatus and middle ear. Prognostic factors and a suggested staging system. J Laryngol Otol. Sep 1985;99(9):847-50. [Medline].
Further Reading
Keywords
temporal bone tumors, temporal bone, malignant tumors of the temporal bone, tumors, cancer of the external auditory canal, cancer of the EAC, temporal bone cancer, cancer of the ear, basal cell carcinoma, squamous cell carcinoma, malignancy of the temporal bone, ear cancer, ear tumor, rhabdomyosarcoma
Treatment: Malignant Tumors of the Temporal Bone